Foreign rare disease treatments start to enter Korea
It was confirmed foreign drug companies’ rare disease therapies or substances that are unknown to Korea were prepared to have clinical trials in Korea. It seems the movement has been led by the growth of the rare disease treatment market, which was globally spread for the past few years.
Based o...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
